FDA to Examine Pancreatic-Duct Metaplasia With IncretinsFDA to Examine Pancreatic-Duct Metaplasia With Incretins

The FDA has issued a drug safety communication alerting patients and doctors to a possible association between incretin mimetic diabetes drugs and precancerous changes in the pancreas. News Alerts
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news